BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38759889)

  • 1. Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8
    Zhu CX; Yan K; Chen L; Huang RR; Bian ZH; Wei HR; Gu XM; Zhao YY; Liu MC; Suo CX; Li ZK; Yang ZY; Lu MQ; Hua XF; Li L; Zhao ZB; Sun LC; Zhang HF; Gao P; Lian ZX
    J Hepatol; 2024 May; ():. PubMed ID: 38759889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinoma.
    Lu Y; Sun Q; Guan Q; Zhang Z; He Q; He J; Ji Z; Tian W; Xu X; Liu Y; Yin Y; Zheng C; Lian S; Xu B; Wang P; Jiang R; Sun B
    J Hepatol; 2023 Nov; 79(5):1172-1184. PubMed ID: 37473847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TREM2
    Tan J; Fan W; Liu T; Zhu B; Liu Y; Wang S; Wu J; Liu J; Zou F; Wei J; Liu L; Zhang X; Zhuang J; Wang Y; Lin H; Huang X; Chen S; Kuang M; Li J
    J Hepatol; 2023 Jul; 79(1):126-140. PubMed ID: 36889359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of miR-99b reprograms tumor-associated macrophage phenotype leading to tumor regression.
    Wang L; Hu YY; Zhao JL; Huang F; Liang SQ; Dong L; Chen Y; Yu HC; Bai J; Yang JM; Fan JY; Feng L; Li SZ; Han H; Qin HY
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway.
    Jiang M; Wang D; Su N; Lou W; Chen Y; Yang H; Chen C; Xi F; Chen Y; Deng L; Tang X
    Int Immunopharmacol; 2024 Feb; 128():111494. PubMed ID: 38218012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages.
    Li Z; Li H; Zhao ZB; Zhu W; Feng PP; Zhu XW; Gong JP
    J Exp Clin Cancer Res; 2019 Nov; 38(1):469. PubMed ID: 31744516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8
    Ma S; Sun B; Duan S; Han J; Barr T; Zhang J; Bissonnette MB; Kortylewski M; He C; Chen J; Caligiuri MA; Yu J
    Nat Immunol; 2023 Feb; 24(2):255-266. PubMed ID: 36658237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking siglec-10
    Xiao N; Zhu X; Li K; Chen Y; Liu X; Xu B; Lei M; Xu J; Sun HC
    Exp Hematol Oncol; 2021 Jun; 10(1):36. PubMed ID: 34112250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
    Jiang Y; Han Q; Zhao H; Zhang J
    J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.
    Wu Q; Zhou W; Yin S; Zhou Y; Chen T; Qian J; Su R; Hong L; Lu H; Zhang F; Xie H; Zhou L; Zheng S
    Hepatology; 2019 Jul; 70(1):198-214. PubMed ID: 30810243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
    Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
    Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A4 enhances protumor macrophage polarization by control of PPAR-γ-dependent induction of fatty acid oxidation.
    Liu S; Zhang H; Li Y; Zhang Y; Bian Y; Zeng Y; Yao X; Wan J; Chen X; Li J; Wang Z; Qin Z
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34145030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function.
    Petty AJ; Dai R; Lapalombella R; Baiocchi RA; Benson DM; Li Z; Huang X; Yang Y
    JCI Insight; 2021 Mar; 6(6):. PubMed ID: 33749663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8
    Luan X; Lei T; Fang J; Liu X; Fu H; Li Y; Chu W; Jiang P; Tong C; Qi H; Fu Y
    Mol Ther; 2024 Feb; 32(2):469-489. PubMed ID: 38098230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGR5 deficiency activates antitumor immunity in non-small cell lung cancer
    Zhao L; Zhang H; Liu X; Xue S; Chen D; Zou J; Jiang H
    Acta Pharm Sin B; 2022 Feb; 12(2):787-800. PubMed ID: 35256947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of Annexin A1 in Tumor-associated Macrophages as a therapeutic strategy for hepatocellular carcinoma.
    Song Z; Wang X; Liu X; Luo Y; Qiu J; Yin A; Liu Y; Yi H; Xiao Z; Li A
    Biochem Pharmacol; 2023 Jul; 213():115612. PubMed ID: 37209858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
    Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF
    Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-98 modulates macrophage polarization and suppresses the effects of tumor-associated macrophages on promoting invasion and epithelial-mesenchymal transition of hepatocellular carcinoma.
    Li L; Sun P; Zhang C; Li Z; Cui K; Zhou W
    Cancer Cell Int; 2018; 18():95. PubMed ID: 29989015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.